Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1097/MPH.0000000000001961 http://scihub22266oqcxt.onion/10.1097/MPH.0000000000001961 33003146!ä!33003146 Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=33003146&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Pediatr+Hematol+Oncol 2021 ; 43 (6): e788-e790 Nephropedia Template TP {{tp|p=33003146|t=2021. A Novel Use of Romiplostim for SARS-CoV-2-induced Thrombocytopenia |pdf=|usr=}}{{33003146}} gab.com Text A Novel Use of Romiplostim for SARS-CoV-2-induced Thrombocytopenia JO: J Pediatr Hematol Oncol http://www.kidney.de/pget.php?&tw=1&pmid=33003146 #FOAvip The literature regarding coronavirus disease of 2019 (COVID-19) infection in pediatrics indicates that children have less severe clinical presentations and lower mortality rates. There remains limited data regarding hematologic sequelae in pediatric patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Romiplostim has shown a platelet response in pediatric patients with chronic immune thrombocytopenic purpura, and eltrombopag is proven to increase platelet counts in patients with inherited thrombocytopenia. We review SARS-CoV-2-associated thrombocytopenia and present a pediatric patient with acute on chronic thrombocytopenia in the setting of COVID-19 with subsequent platelet recovery using romiplostim. Twit Text FOAVip A Novel Use of Romiplostim for SARS-CoV-2-induced Thrombocytopenia ????J Pediatr Hematol Oncol http://www.kidney.de/pget.php?&tw=1&pmid=33003146 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33003146 #FOAvip English Wikipedia <ref>{{Cite pmid|33003146}}</ref> A Novel Use of Romiplostim for SARS-CoV-2-induced Thrombocytopenia #MMPMID33003146 Schneider CW; Penney SW; Helfrich AM; Hartman KR; Lieuw K J Pediatr Hematol Oncol 2021[Aug]; 43 (6): e788-e790 PMID33003146show ga The literature regarding coronavirus disease of 2019 (COVID-19) infection in pediatrics indicates that children have less severe clinical presentations and lower mortality rates. There remains limited data regarding hematologic sequelae in pediatric patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Romiplostim has shown a platelet response in pediatric patients with chronic immune thrombocytopenic purpura, and eltrombopag is proven to increase platelet counts in patients with inherited thrombocytopenia. We review SARS-CoV-2-associated thrombocytopenia and present a pediatric patient with acute on chronic thrombocytopenia in the setting of COVID-19 with subsequent platelet recovery using romiplostim. |COVID-19/*complications/transmission/virology[MESH] |Child[MESH] |Humans[MESH] |Male[MESH] |Receptors, Fc/*therapeutic use[MESH] |Recombinant Fusion Proteins/*therapeutic use[MESH] |SARS-CoV-2/*isolation & purification[MESH] |Thrombocytopenia/*drug therapy/pathology/virology[MESH]A Novel Use of Romiplostim for SARS-CoV-2-induced Thrombocytopenia (epmc).pdf DeepDyve Pubget Overpricing